Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Axillary Lymph Node Dissection Versus Axillary Radiotherapy in Breast Cancer Patients With Positive Sentinel Node After Neoadjuvant Therapy: A Multicenter Randomized Study

NCT04889924 is registered in ClinicalTrials.gov with Hospital Universitari de Bellvitge as lead sponsor.

NCT NCT04889924
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04889924 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Axillary Lymph Node Dissection Versus Axillary Radiotherapy in Breast Cancer Patients With Positive Sentinel Node After Neoadjuvant Therapy: A Multicenter Randomized Study
Lead sponsor
Hospital Universitari de Bellvitge
Phase
Not applicable
Overall status
Recruiting
Start date
June 11, 2021
Completion date
December 31, 2028
Enrollment
820 (estimated)
Sites
61

Conditions

As the registry lists them; a condition with its own page is linked.

axillary lymph nodes dissection, breast cancer, chemotherapy, radiotherapy side effect, sentinel lymph node